Integer (NYSE:ITGR) Downgraded to “Strong Sell” Rating by Zacks Research

Zacks Research lowered shares of Integer (NYSE:ITGR) from a hold rating to a strong sell rating in a research report released on Monday morning,Zacks.com reports.

Other equities analysts have also recently issued reports about the stock. Truist Financial raised their target price on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Friday, February 20th. Citigroup dropped their price objective on shares of Integer from $92.00 to $89.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Wells Fargo & Company increased their price objective on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, February 20th. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Four investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Integer presently has an average rating of “Hold” and an average target price of $98.29.

Integer Stock Performance

Shares of NYSE ITGR opened at $85.15 on Monday. The firm has a fifty day moving average price of $86.07 and a 200-day moving average price of $80.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The stock has a market cap of $2.89 billion, a PE ratio of 21.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.67. Integer has a 1 year low of $62.00 and a 1 year high of $123.78.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million during the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the company earned $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities analysts anticipate that Integer will post 6.11 earnings per share for the current fiscal year.

Insider Activity at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This trade represents a 15.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Integer

Several institutional investors have recently made changes to their positions in ITGR. Salomon & Ludwin LLC lifted its stake in shares of Integer by 46.8% in the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 118 shares during the period. Kestra Advisory Services LLC lifted its stake in shares of Integer by 0.6% in the 4th quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock valued at $1,680,000 after purchasing an additional 136 shares during the period. Orion Porfolio Solutions LLC lifted its stake in shares of Integer by 1.4% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock valued at $1,200,000 after purchasing an additional 138 shares during the period. Lido Advisors LLC lifted its stake in shares of Integer by 5.5% in the 4th quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock valued at $226,000 after purchasing an additional 151 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Integer by 9.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 1,979 shares of the medical equipment provider’s stock valued at $205,000 after purchasing an additional 166 shares during the period. Institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.